EUVIMEDEUVIMED entdecken
Open Access

Neuropsychiatric symptoms in sporadic Creutzfeldt-Jakob disease

Jennifer Zitser iD, Sven Forner, Katherine Wong, Jin Chengshi, John Neuhaus, Jennifer Martindale, Ben J Raudabaugh, Kendra Benisano, Kelly Goodman-O'Leary, Stacy Metcalf, Mee-Ohk Kim, Marwa Hakimi und 5 weitere

Brain · 08.01.2026 · 149 (1) · 262-273

DOI: 10.1093/brain/awaf077 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Brain, online erschienen am 28.03.2025. Verfasst von Jennifer Zitser und 16 weiteren Autor:innen. Beteiligte Einrichtung: Memory and Aging Center, University of California, San Francisco, San Francisco, CA 94158, USA. Hauptthemen laut MEDLINE: Creutzfeldt-Jakob Syndrome. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 87 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Michael J. Homer Family Fund, NINDS NIH HHS, NIA NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Although neuropsychiatric symptoms are not part of diagnostic criteria for sporadic Creutzfeldt-Jakob disease (sCJD), a few retrospective studies and our clinical experience have suggested they are prominent and often occur early. The objective of our study was to assess prospectively the neuropsychiatric features in sCJD (and their impact on caregivers) and compare them with five other neurodegenerative diseases: Alzheimer’s disease (AD), dementia with Lewy bodies (DLB), progressive supranuclear palsy, behavioural variant frontotemporal dementia (bvFTD) and semantic variant primary progressive aphasia. The Neuropsychiatric Inventory (NPI) was given at the first UCSF research visit to caregivers of 789 serial patients evaluated at the UCSF Memory and Aging Center from January 2000 through November 2016 who met the diagnostic research criteria for one of these six neurodegenerative disorders. All subjects underwent a Mini-Mental State Examination, and demographic data (age, sex, years of education) were collected. We hypothesized that sCJD has a very prominent behavioural and neuropsychiatric profile, which might help to distinguish it from other neurodegenerative diseases. Of our sCJD cohort (n = 92), 97% exhibited at least one and 50% at least six of the 12 symptoms on the NPI at the time of their first research visit. The most common behavioural symptoms, which occurred in >50% of the sCJD patient cohort, were: appetite/eating disturbances (68%), apathy/indifference (66%), night-time behaviour disturbances (53%), aberrant motor behaviour (53%) and anxiety (52%). Even the least common behaviour, disinhibition, occurred in 19%. Compared with DLB and bvFTD, two conditions with very prominent behavioural features that are included in their diagnostic criteria, sCJD had significantly higher mean NPI frequency × severity scores for night-time behaviour disturbances and delusions. Patients with sCJD scored higher for hallucinations and dysphoria than bvFTD patients and higher for appetite/eating disturbances, aberrant motor behaviour and agitation than patients with DLB. sCJD resulted in significantly worse frequency × severity scores than AD in nine of the NPI symptom domains, with our data revealing sCJD to be a highly behavioural syndrome. No neuropsychiatric symptom is pathognomonic for sCJD, but specific symptoms may enable the differentiation of sCJD from other neurodegenerative diseases. Our findings support the inclusion of behavioural symptoms in sCJD diagnostic criteria.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Creutzfeldt-Jakob SyndromeHumansMaleFemaleAgedMiddle AgedAged, 80 and overNeuropsychological TestsFrontotemporal DementiaAlzheimer DiseaseLewy Body DiseaseProspective StudiesSupranuclear Palsy, ProgressiveNeurodegenerative Diseases

Stichwörter der Autor:innen

CJDJakob-Creutzfeldt diseasemanagementprion diseasetransmissible spongiform encephalopathy

Autor:innen und Institutionen

  • Memory and Aging Center, University of California, San Francisco, San Francisco, CA 94158, USA.
  • Global Brain Health Institute, University of California, San Francisco, San Francisco, CA 94158, USA.
  • Movement Disorders Unit, Department of Neurology, Tel Aviv Sourasky Medical Center, affiliated to the Sackler Faculty of Medicine, Tel-Aviv University, Tel Aviv 6423906, Israel.
  • Department of Epidemiology & Biostatistics, University of California, San Francisco, San Francisco, CA 94158, USA.

ORCID-Profile: Jennifer Zitser

Förderung

  • Michael J. Homer Family Fund
  • NINDS NIH HHS
  • NIA NIH HHS
  • NCRR NIH HHS
  • NIH HHS
  • National Institutes of Health
  • National Institute on Aging
  • National Institute of Neurological Disorders and Stroke

Zitieren

APA

Zitser, J., Forner, S., Wong, K., Chengshi, J., Neuhaus, J., Martindale, J., Raudabaugh, B. J., Benisano, K., Goodman-O'Leary, K., Metcalf, S., Kim, M. O., Hakimi, M., Allen, I. E., Miller, B. L., Rosen, H. J., Rankin, K. P., & Geschwind, M. D. (2026). Neuropsychiatric symptoms in sporadic Creutzfeldt-Jakob disease. Brain, 149(1), 262-273. https://doi.org/10.1093/brain/awaf077

Vancouver

Zitser J, Forner S, Wong K, Chengshi J, Neuhaus J, Martindale J, et al. Neuropsychiatric symptoms in sporadic Creutzfeldt-Jakob disease. Brain. 2026;149(1):262-273. doi:10.1093/brain/awaf077

BibTeX
@article{Zitser2026,
  author = {Zitser, Jennifer and Forner, Sven and Wong, Katherine and Chengshi, Jin and Neuhaus, John and Martindale, Jennifer and Raudabaugh, Ben J and Benisano, Kendra and Goodman-O'Leary, Kelly and Metcalf, Stacy and Kim, Mee-Ohk and Hakimi, Marwa and Allen, Isabelle E and Miller, Bruce L and Rosen, Howard J and Rankin, Katherine P and Geschwind, Michael D},
  title = {Neuropsychiatric symptoms in sporadic Creutzfeldt-Jakob disease},
  journal = {Brain},
  year = {2026},
  volume = {149},
  number = {1},
  pages = {262--273},
  doi = {10.1093/brain/awaf077}
}
Kostenlos starten →